| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |